Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Similar Incidence of Severe Acute Gvhd and Less Extensive Chronic Gvhd in PBSCT from Unmanipulated Haploidentical Donor Compared with That from Matched Sibling Donor for Patients with Hematologic Malignancies

Honghua Li, Wenrong Huang, Chunji Gao, Liping Dou, Fei Li, Quanshun Wang, Lili Wang, Li Yu, Dai-Hong Liu

Blood (2015) 126 (23): 1964.

https://doi.org/10.1182/blood.V126.23.1964.1964

Published: 2015

Journal Articles

Similar Outcomes of Allogeneic Hematopoietic Cell Transplantation from Matched Sibling Donor and Haploidentical Donor for Refractory/Relapsed Acute Myeloid Leukemia

Dai-Hong Liu, Li Yu, Wenrong Huang, Liping Dou, Honghua Li, Gao Chunji, Bo Jian, Fei Li, Lili Wang

Blood (2015) 126 (23): 5511.

https://doi.org/10.1182/blood.V126.23.5511.5511

Published: 2015

Journal Articles

Allogeneic Halpo-Identical Hematopoietic Stem Cell Transplantation for High-Risk Leukemia

Jing Bo Wang, PhD, Xin Hong Fei, Yu Ming Yin, Hao Yu Cheng, Wei Jie Zhang, Jiang Ying Gu, Song Xue, Qian Li, Fan Yang, Shu Qin Zhang, Jun Bao He, Meng Qi Liu, Jie Zhao, Dai-Hong Liu

Blood (2015) 126 (23): 5514.

https://doi.org/10.1182/blood.V126.23.5514.5514

Published: 2015

Journal Articles

Effect of Transfusion of the Third Party Umbilical Cord Blood on Haplo-Identical Hematopoietic Stem Cell Transplantation

Jing Bo Wang, PhD, Xin Hong Fei, Hao Yu Cheng, Yu Ming Yin, Wei Jie Zhang, Shu Qin Zhang, Qian Li, Song Xue, Jiang Ying Gu, Jun Bao He, Fan Yang, Meng Qi Liu, Jie Zhao, Dai-Hong Liu

Blood (2015) 126 (23): 1943.

https://doi.org/10.1182/blood.V126.23.1943.1943

Published: 2015

Journal Articles

Haploidentical Unmanipulated G-CSF-Primed Peripheral Blood Stem Cell Transplantation for Patients with High-Risk Hematologic Malignancies

Dai-Hong Liu, Doctor, Li Yu, Wenrong Huang, Liping Dou, Honghua Li, Chunji Gao, Jian Bo, Fei Li, Lili Wang

Blood (2015) 126 (23): 4365.

https://doi.org/10.1182/blood.V126.23.4365.4365

Published: 2015

Journal Articles

Risk-Stratification Directed Prophylaxis with Additional Low-Dose of Methylprednisolone Can Reduce Acute Graft-Versus-Host Disease for Patients with Hematological Malignancies after Allogeneic SCT: A Randomized, Controlled, Clinical Trial

Ying-Jun Chang, Yu Wang, Lan-Ping Xu, Dai-Hong Liu, Kai-Yan Liu, Xiao-Hui Zhang, MD, PhD, Fei-Fei Tang, Huan Chen, Yu-Hong Chen, Xiao-Dong Mo, MD, Wei Han, MD, Chen-Hua Yan, Feng-Rong Wang, Yu-Qian Sun, Xiao Jun Huang

Blood (2014) 124 (21): 40.

https://doi.org/10.1182/blood.V124.21.40.40

Published: 2014

Journal Articles

Haplo-Identical Hematopoietic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome: Similar Survival in Comparison with HLA-Identical Siblings: Multi-Center, Prospective Study

Yu Wang, Wu Depei, Qifa Liu, MD, Lin Liu, Feng Gao, Jian ou-Yang, Dai-Hong Liu, MD PhD, Lan-Ping Xu, Xiao-Jun Huang, MDPhD

Blood (2014) 124 (21): 1231.

https://doi.org/10.1182/blood.V124.21.1231.1231

Published: 2014

Journal Articles

Who is the best donor for a related HLA haplotype-mismatched transplant?

Yu Wang, Ying-Jun Chang, Lan-Ping Xu, Kai-Yan Liu, Dai-Hong Liu, Xiao-Hui Zhang, Huan Chen, Wei Han, Yu-Hong Chen, Feng-Rong Wang, Jing-Zhi Wang, Yao Chen, Chen-Hua Yan, Ming-Rui Huo, Dan Li, Xiao-Jun Huang

Blood (2014) 124 (6): 843–850.

https://doi.org/10.1182/blood-2014-03-563130

Published: 2014

Journal Articles

Effects Of Noninherited Maternal Antigen On The Occurrence Of Acute Graft-Versus Host Diseae After Unmanipulated Haploidentical Blood and Marrow Transplantation

Ying-Jun Chang, Ph.D, Dai-Hong Liu, MD, PhD, Kaiyan Liu, Lan-Ping Xu, Yu Wang, Ming-Rui Huo, Huan Chen, Wei Han, MD, Yu-Hong Chen, Feng-Rong Wang, Jing-Zhi Wang, Yao Chen, Chen-Hua Yan, Xiao-Jun Huang, MD, PhD

Blood (2013) 122 (21): 3301.

https://doi.org/10.1182/blood.V122.21.3301.3301

Published: 2013

Journal Articles

Low WT1 Expression At Diagnosis Is a Strong Predictor On Poor Outcome In Patients With t(8;21) Acute Myeloid Leukemia

Ya-Zhen Qin, MS, Hong-Hu Zhu, MD, Qian Jiang, Dai-Hong Liu, MD, PhD, Hao Jiang, Lan-Ping Xu, MD, Huan Chen, Yu Wang, MD, Xiao-hui Zhang, MD, PhD, Jun-Yue Chai MM, Li-Ru Wang, MD, Yan-Rong Liu, MS, Xiao-Jun Huang, MD, PhD

Blood (2013) 122 (21): 1346.

https://doi.org/10.1182/blood.V122.21.1346.1346

Published: 2013

Journal Articles

CD34 + CD38 - CD58 - Candidate Leukemia-Initiating Cells Are Clinically Relevant With The Unfavorable Prognosis In Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Yuan kong, MD, PhD, Ying-Jun Chang, PhD, Yan-rong Liu, MD, Ya-zhe Wang, Qian Jiang, Hao Jiang, Ya-Zhen Qin, MS, Jing Wang, Hong-Hu Zhu, MD, Yue-Yun Lai, Lanping Xu, Dai-Hong Liu, MD, PhD, Xiao-Jun Huang, MD, PhD

Blood (2013) 122 (21): 354.

https://doi.org/10.1182/blood.V122.21.354.354

Published: 2013

Journal Articles

MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial

Blood (2013) 121 (20): 4056–4062.

https://doi.org/10.1182/blood-2012-11-468348

Published: 2013

Includes: Supplemental data

Journal Articles

Risk-Stratification Treatment Directed by Minimal Residual Disease Improves the Outcome of Acute Myeloid Leukemia with t(8;21) in First Complete Remission: Results of the AML05 Multicentre Trial

Honghu Zhu, PhD, Xiao-hui Zhang, MD, PhD, Yazhen Qin, Hao Jiang, MD, Dai-Hong Liu, MD, PhD, Huan Chen, Qian Jiang, MD, Jun-Yue Chai, Li-Ru Wang, Xiaojun Huang

Blood (2012) 120 (21): 139.

https://doi.org/10.1182/blood.V120.21.139.139

Published: 2012

Journal Articles

CD58-Negtive Leukemia Initiating Cells Are Independently Associated with High Risk of Relapse in B-Precursor Acute Lymphoblastic Leukemia: A Comprehensive Clinical and Biological Profiling Study

Yuan Kong, MD, PhD, Yanrong Liu, MD, Honghu Zhu, PhD, Qian Jiang, MD, Hao Jiang, MD, Lan-Ping Xu, MD, Dai-Hong Liu, MD, PhD, Guo-Rui Ruan, PhD, Bin Jiang, MD, Kaiyan Liu, MD, Xiao-jun Huang, MD, PhD

Blood (2012) 120 (21): 1397.

https://doi.org/10.1182/blood.V120.21.1397.1397

Published: 2012

Journal Articles

Characterization of TPO Kinetics within 60 Days of Allogeneic Hematopoietic Stem Cell Transplantation and Its Correlation with Megakaryocyte Ploidy Distribution

Xiao-hui Zhang, MD, PhD, Hai-xia Fu, MD, Dai-Hong Liu, MD, PhD, Lan-Ping Xu, MD, Kai-Yan Liu, MD, Xiao-Jun Huang, MD

Blood (2012) 120 (21): 4463.

https://doi.org/10.1182/blood.V120.21.4463.4463

Published: 2012

Journal Articles

All-Trance Retinoid Acid (ATRA) Makes Refractory Immune Thrombocytopenia (RITP) Less Refractory: A Retrospective Study of Ritp Patients Treated with Combination Therapies Including ATRA

Min Wang, MD, Xiao-hui Zhang, MD, PhD, Wei Han, MD, Yu Wang, MD, Dai-Hong Liu, MD, PhD, Lan-Ping Xu, MD, Kai-Yan Liu, MD, Hai-xia Fu, MD, Meng Lv, MD, Yi Zhou, MD, Xiao-Jun Huang, MD

Blood (2012) 120 (21): 3338.

https://doi.org/10.1182/blood.V120.21.3338.3338

Published: 2012

Journal Articles

The superiority of haploidentical related stem cell transplantation over chemotherapy alone as postremission treatment for patients with intermediate- or high-risk acute myeloid leukemia in first complete remission

Xiao-Jun Huang, Hong-Hu Zhu, Ying-Jun Chang, Lan-Ping Xu, Dai-Hong Liu, Xiao-Hui Zhang, Bin Jiang, Qian Jiang, Hao Jiang, Yu-Hong Chen, Huan Chen, Wei Han, Kai-Yan Liu, Yu Wang

Blood (2012) 119 (23): 5584–5590.

https://doi.org/10.1182/blood-2011-11-389809

Published: 2012

Includes: Supplemental data

Journal Articles

Risk stratification–directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation

Chen-Hua Yan, Dai-Hong Liu, Kai-Yan Liu, Lan-Ping Xu, Yan-Rong Liu, Huan Chen, Wei Han, Yu Wang, Ya-Zhen Qin, Xiao-Jun Huang

Blood (2012) 119 (14): 3256–3262.

https://doi.org/10.1182/blood-2011-09-380386

Published: 2012

Journal Articles

Imatinib Mesylate Is Superior to Allogeneic Hematopoietic Stem Cell Transplantation As the First-Line Therapy for Patients with Chronic Myeloid Leukemia in the Early Chronic Phase

Blood (2011) 118 (21): 162.

https://doi.org/10.1182/blood.V118.21.162.162

Published: 2011

Journal Articles

Imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in the accelerated phase

Qian Jiang, Lan-Ping Xu, Dai-Hong Liu, Kai-Yan Liu, Shan-Shan Chen, Bin Jiang, Hao Jiang, Huan Chen, Yu-Hong Chen, Wei Han, Xiao-Hui Zhang, Yu Wang, Ya-Zhen Qin, Yan-Rong Liu, Yue-Yun Lai, Xiao-Jun Huang

Blood (2011) 117 (11): 3032–3040.

https://doi.org/10.1182/blood-2010-09-308510

Published: 2011

NARROW

Similar Incidence of Severe Acute Gvhd and Less Extensive Chronic Gvhd in PBSCT from Unmanipulated Haploidentical Donor Compared with That from Matched Sibling Donor for Patients with Hematologic Malignancies

Similar Outcomes of Allogeneic Hematopoietic Cell Transplantation from Matched Sibling Donor and Haploidentical Donor for Refractory/Relapsed Acute Myeloid Leukemia

Allogeneic Halpo-Identical Hematopoietic Stem Cell Transplantation for High-Risk Leukemia

Effect of Transfusion of the Third Party Umbilical Cord Blood on Haplo-Identical Hematopoietic Stem Cell Transplantation

Haploidentical Unmanipulated G-CSF-Primed Peripheral Blood Stem Cell Transplantation for Patients with High-Risk Hematologic Malignancies

Risk-Stratification Directed Prophylaxis with Additional Low-Dose of Methylprednisolone Can Reduce Acute Graft-Versus-Host Disease for Patients with Hematological Malignancies after Allogeneic SCT: A Randomized, Controlled, Clinical Trial

Haplo-Identical Hematopoietic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome: Similar Survival in Comparison with HLA-Identical Siblings: Multi-Center, Prospective Study

Who is the best donor for a related HLA haplotype-mismatched transplant?

Effects Of Noninherited Maternal Antigen On The Occurrence Of Acute Graft-Versus Host Diseae After Unmanipulated Haploidentical Blood and Marrow Transplantation

Low WT1 Expression At Diagnosis Is a Strong Predictor On Poor Outcome In Patients With t(8;21) Acute Myeloid Leukemia

CD34 + CD38 - CD58 - Candidate Leukemia-Initiating Cells Are Clinically Relevant With The Unfavorable Prognosis In Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial

Risk-Stratification Treatment Directed by Minimal Residual Disease Improves the Outcome of Acute Myeloid Leukemia with t(8;21) in First Complete Remission: Results of the AML05 Multicentre Trial

CD58-Negtive Leukemia Initiating Cells Are Independently Associated with High Risk of Relapse in B-Precursor Acute Lymphoblastic Leukemia: A Comprehensive Clinical and Biological Profiling Study

Characterization of TPO Kinetics within 60 Days of Allogeneic Hematopoietic Stem Cell Transplantation and Its Correlation with Megakaryocyte Ploidy Distribution

All-Trance Retinoid Acid (ATRA) Makes Refractory Immune Thrombocytopenia (RITP) Less Refractory: A Retrospective Study of Ritp Patients Treated with Combination Therapies Including ATRA

The superiority of haploidentical related stem cell transplantation over chemotherapy alone as postremission treatment for patients with intermediate- or high-risk acute myeloid leukemia in first complete remission

Risk stratification–directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation

Imatinib Mesylate Is Superior to Allogeneic Hematopoietic Stem Cell Transplantation As the First-Line Therapy for Patients with Chronic Myeloid Leukemia in the Early Chronic Phase

Imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in the accelerated phase

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only